TRIL at $1.30US, fair value estimate is $24.TRIL put out fantastic results yesterday. Their CD-47 drugs have the potential to be best in class, providing another meaningful tool in the fight against cancer... their closest competitor is valued at a market cap that would suggest a comparable price for TRIL of $24US.